These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 24617941

  • 1. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.
    Pathak RK, Marrache S, Harn DA, Dhar S.
    ACS Chem Biol; 2014 May 16; 9(5):1178-87. PubMed ID: 24617941
    [Abstract] [Full Text] [Related]

  • 2. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL, Park JY, Kim EH, Jang HJ, Kwon M.
    Cancer Lett; 2016 Feb 01; 371(1):20-9. PubMed ID: 26607904
    [Abstract] [Full Text] [Related]

  • 3. Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate.
    Yang J, Cao Q, Zhang H, Hao L, Zhou D, Gan Z, Li Z, Tong YX, Ji LN, Mao ZW.
    Biomaterials; 2018 Sep 01; 176():94-105. PubMed ID: 29870900
    [Abstract] [Full Text] [Related]

  • 4. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
    Stockwin LH, Yu SX, Borgel S, Hancock C, Wolfe TL, Phillips LR, Hollingshead MG, Newton DL.
    Int J Cancer; 2010 Dec 01; 127(11):2510-9. PubMed ID: 20533281
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs.
    Heshe D, Hoogestraat S, Brauckmann C, Karst U, Boos J, Lanvers-Kaminsky C.
    Cancer Chemother Pharmacol; 2011 Mar 01; 67(3):647-55. PubMed ID: 20502900
    [Abstract] [Full Text] [Related]

  • 7. Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity.
    Trapella C, Voltan R, Melloni E, Tisato V, Celeghini C, Bianco S, Fantinati A, Salvadori S, Guerrini R, Secchiero P, Zauli G.
    J Med Chem; 2016 Jan 14; 59(1):147-56. PubMed ID: 26653539
    [Abstract] [Full Text] [Related]

  • 8. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA, De Preter G, Joudiou N, Bol A, Brender JR, Saito K, Kishimoto S, Grégoire V, Jordan BF, Krishna MC, Feron O, Gallez B.
    Oncotarget; 2016 Dec 06; 7(49):81741-81749. PubMed ID: 28082726
    [Abstract] [Full Text] [Related]

  • 9. Dual-targeting of aberrant glucose metabolism in glioblastoma.
    Shen H, Decollogne S, Dilda PJ, Hau E, Chung SA, Luk PP, Hogg PJ, McDonald KL.
    J Exp Clin Cancer Res; 2015 Feb 05; 34(1):14. PubMed ID: 25652202
    [Abstract] [Full Text] [Related]

  • 10. The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis.
    Nikravesh H, Khodayar MJ, Behmanesh B, Mahdavinia M, Teimoori A, Alboghobeish S, Zeidooni L.
    BMC Cancer; 2021 Aug 07; 21(1):903. PubMed ID: 34364387
    [Abstract] [Full Text] [Related]

  • 11. Targeting of two aspects of metabolism in breast cancer treatment.
    Gang BP, Dilda PJ, Hogg PJ, Blackburn AC.
    Cancer Biol Ther; 2014 Aug 07; 15(11):1533-41. PubMed ID: 25482950
    [Abstract] [Full Text] [Related]

  • 12. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
    Tataranni T, Agriesti F, Pacelli C, Ruggieri V, Laurenzana I, Mazzoccoli C, Sala GD, Panebianco C, Pazienza V, Capitanio N, Piccoli C.
    Cells; 2019 May 18; 8(5):. PubMed ID: 31109089
    [Abstract] [Full Text] [Related]

  • 13. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
    Kumar A, Kant S, Singh SM.
    Toxicol Appl Pharmacol; 2013 Nov 15; 273(1):196-208. PubMed ID: 24051182
    [Abstract] [Full Text] [Related]

  • 14. Dichloroacetate induces apoptosis in endometrial cancer cells.
    Wong JY, Huggins GS, Debidda M, Munshi NC, De Vivo I.
    Gynecol Oncol; 2008 Jun 15; 109(3):394-402. PubMed ID: 18423823
    [Abstract] [Full Text] [Related]

  • 15. Effect of dichloroacetate on Lewis lung carcinoma growth and metastasis.
    Kolesnik DL, Pyaskovskaya ON, Boychuk IV, Dasyukevich OI, Melnikov OR, Tarasov AS, Solyanik GI.
    Exp Oncol; 2015 Jun 15; 37(2):126-9. PubMed ID: 26112940
    [Abstract] [Full Text] [Related]

  • 16. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells.
    Choi YW, Lim IK.
    Cancer Lett; 2014 May 01; 346(2):300-8. PubMed ID: 24480191
    [Abstract] [Full Text] [Related]

  • 17. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.
    Ruggieri V, Agriesti F, Scrima R, Laurenzana I, Perrone D, Tataranni T, Mazzoccoli C, Lo Muzio L, Capitanio N, Piccoli C.
    Oncotarget; 2015 Jan 20; 6(2):1217-30. PubMed ID: 25544754
    [Abstract] [Full Text] [Related]

  • 18. Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.
    Sun RC, Board PG, Blackburn AC.
    Mol Cancer; 2011 Nov 18; 10():142. PubMed ID: 22093145
    [Abstract] [Full Text] [Related]

  • 19. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A, Dromparis P, Saleme B, Gurtu V, Watson K, Paulin R, Zervopoulos S, Stenson T, Sutendra G, Pink DB, Carmine-Simmen K, Moore R, Lewis JD, Michelakis ED.
    Eur Urol; 2016 Apr 18; 69(4):734-744. PubMed ID: 26433571
    [Abstract] [Full Text] [Related]

  • 20. Hypoxia enhances antitumor activity of dichloroacetate.
    Kolesnik DL, Pyaskovskaya ON, Boichuk IV, Solyanik GI.
    Exp Oncol; 2014 Dec 18; 36(4):231-5. PubMed ID: 25537215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.